Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system
Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood
14 Apr 2021
2 abstracts by Epimune's collaborators selected for presentation at the CIS 2021 Virtual Annual Meeting
For a Spanish version of this video please click here!